A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

Mansoor Raza Mirza, Bente Lund, Jacob Christian Lindegaard, Nina Keldsen, Anders Mellemgaard, René dePont Christensen, Kamma Bertelsen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

11 Citationer (Scopus)

Abstract

Treatment of epithelial ovarian cancer patients relapsing with a short treatment-free interval (TFI) after prior chemotherapy is unsatisfactory. This phase II trial evaluated the activity and feasibility of pegylated liposomal doxorubicin (PLD) plus gemcitabine in this setting.
OriginalsprogEngelsk
TidsskriftJournal of Gynecologic Oncology Nursing
Vol/bind119
Udgave nummer1
Sider (fra-til)26-31
Antal sider6
ISSN1536-9935
DOI
StatusUdgivet - 1 okt. 2010

Citationsformater